Skip to main content
Fig. 5 | Diabetology & Metabolic Syndrome

Fig. 5

From: Low dose chloroquine decreases insulin resistance in human metabolic syndrome but does not reduce carotid intima-media thickness

Fig. 5

Blood pressure and lipid responses in the yearlong chloroquine trial. a Diastolic blood pressure over 24 months determined by conventional testing. b–d Blood pressures over 12 months, determined by an ambulatory monitoring device. e–i Lipids and lipoproteins over 24 months. P values were determined by mixed model treatment of repeated measures

Back to article page

Diabetology & Metabolic Syndrome

ISSN: 1758-5996

Contact us